Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 55571

1.

Online Tremor Suppression Using Electromyography and Low Level Electrical Stimulation.

Dosen S, Muceli S, Dideriksen J, Romero J, Rocon E, Pons J, Farina D.

IEEE Trans Neural Syst Rehabil Eng. 2014 Jul 15. [Epub ahead of print]

PMID:
25051555
[PubMed - as supplied by publisher]
2.

Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts.

Kraemmer J, Kovacs GG, Perju-Dumbrava L, Pirker S, Traub-Weidinger T, Pirker W.

Mov Disord. 2014 Jul 22. doi: 10.1002/mds.25975. [Epub ahead of print]

PMID:
25048738
[PubMed - as supplied by publisher]
3.

The impact of STN deep brain stimulation on speech in individuals with Parkinson's disease: The patient's perspective.

Wertheimer J, Gottuso AY, Nuno M, Walton C, Duboille A, Tuchman M, Ramig L.

Parkinsonism Relat Disord. 2014 Jun 27. pii: S1353-8020(14)00230-2. doi: 10.1016/j.parkreldis.2014.06.010. [Epub ahead of print]

PMID:
25048615
[PubMed - as supplied by publisher]
4.

Natural history of falls in a population-based cohort of patients with Parkinson's disease: An 8-year prospective study.

Hiorth YH, Larsen JP, Lode K, Pedersen KF.

Parkinsonism Relat Disord. 2014 Jul 9. pii: S1353-8020(14)00243-0. doi: 10.1016/j.parkreldis.2014.06.023. [Epub ahead of print]

PMID:
25048614
[PubMed - as supplied by publisher]
5.

The association of heart rate variability with parkinsonian motor symptom duration.

Harnod D, Wen SH, Chen SY, Harnod T.

Yonsei Med J. 2014 Sep 1;55(5):1297-302. doi: 10.3349/ymj.2014.55.5.1297.

PMID:
25048488
[PubMed - in process]
6.

Impulse control and repetitive behaviors in Parkinson's disease - Are there differences in the relation to dopamine agonist treatment?

Somme JH, Gómez-Esteban JC, Tijero B, Berganzo K, Lezcano E, Zarranz JJ.

J Neurol Sci. 2014 Jul 9. pii: S0022-510X(14)00447-X. doi: 10.1016/j.jns.2014.07.004. [Epub ahead of print] No abstract available.

PMID:
25048409
[PubMed - as supplied by publisher]
7.

A cell culture model for monitoring α-synuclein cell-to-cell transfer.

Reyes JF, Olsson TT, Lamberts JT, Devine MJ, Kunath T, Brundin P.

Neurobiol Dis. 2014 Jul 16. pii: S0969-9961(14)00197-1. doi: 10.1016/j.nbd.2014.07.003. [Epub ahead of print]

PMID:
25046995
[PubMed - as supplied by publisher]
8.

The measurement and importance of non-motor symptoms in Parkinson disease.

Schapira AH.

Eur J Neurol. 2014 Jul 21. doi: 10.1111/ene.12523. [Epub ahead of print] No abstract available.

PMID:
25046771
[PubMed - as supplied by publisher]
9.

Analysis of Dosage Mutation in PARK2 among Korean Patients with Early-Onset or Familial Parkinson's Disease.

Chu MK, Kim WC, Choi JM, Hong JH, Kang SY, Ma HI, Kim YJ.

J Clin Neurol. 2014 Jul;10(3):244-8. doi: 10.3988/jcn.2014.10.3.244. Epub 2014 Jul 3.

PMID:
25045378
[PubMed]
Free Article
10.

Frequency-dependent neural activity in Parkinson's disease.

Hou Y, Wu X, Hallett M, Chan P, Wu T.

Hum Brain Mapp. 2014 Jul 12. doi: 10.1002/hbm.22587. [Epub ahead of print]

PMID:
25045127
[PubMed - as supplied by publisher]
11.

Methyl Yellow: A Potential Drug Scaffold for Parkinson's Disease.

Geldenhuys WJ, Kochi A, Lin L, Sutariya V, Dluzen DE, Van der Schyf CJ, Lim MH.

Chembiochem. 2014 Jul 8. doi: 10.1002/cbic.201300770. [Epub ahead of print]

PMID:
25045125
[PubMed - as supplied by publisher]
12.

Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease.

Borgohain R, Szasz J, Stanzione P, Meshram C, Bhatt MH, Chirilineau D, Stocchi F, Lucini V, Giuliani R, Forrest E, Rice P, Anand R; the Study 018 Investigators11.

Mov Disord. 2014 Jul 10. doi: 10.1002/mds.25961. [Epub ahead of print]

PMID:
25044402
[PubMed - as supplied by publisher]
13.

Flt3 ligand does not differentiate between Parkinsonian disorders.

Silajdžić E, Constantinescu R, Holmberg B, Björkqvist M, Hansson O.

Mov Disord. 2014 Jul 16. doi: 10.1002/mds.25948. [Epub ahead of print]

PMID:
25044107
[PubMed - as supplied by publisher]
14.

The clinical spectrum of anxiety in Parkinson's disease.

Dissanayaka NN, White E, O'Sullivan JD, Marsh R, Pachana NA, Byrne GJ.

Mov Disord. 2014 Jul;29(8):967-75. doi: 10.1002/mds.25937.

PMID:
25043800
[PubMed - in process]
15.

Freezing of gait in Chinese patients with Parkinson Disease.

Ou R, Guo X, Song W, Cao B, Yang J, Wei Q, Shao N, Shang H.

J Neurol Sci. 2014 Jul 8. pii: S0022-510X(14)00445-6. doi: 10.1016/j.jns.2014.07.002. [Epub ahead of print]

PMID:
25043665
[PubMed - as supplied by publisher]
16.

Carboxyfullerene neuroprotection postinjury in Parkinsonian nonhuman primates.

Dugan LL, Tian L, Quick KL, Hardt JI, Karimi M, Brown C, Loftin S, Flores H, Moerlein SM, Polich J, Tabbal SD, Mink JW, Perlmutter JS.

Ann Neurol. 2014 Jul 8. doi: 10.1002/ana.24220. [Epub ahead of print]

PMID:
25043598
[PubMed - as supplied by publisher]
17.

Effects of external cues on gait parameters of Parkinson's disease patients: A systematic review.

Rocha PA, Porfírio GM, Ferraz HB, Trevisani VF.

Clin Neurol Neurosurg. 2014 Jul 5;124C:127-134. doi: 10.1016/j.clineuro.2014.06.026. [Epub ahead of print] Review.

PMID:
25043443
[PubMed - as supplied by publisher]
18.

Subpicomolar diphenyleneiodonium inhibits microglial NADPH oxidase with high specificity and shows great potential as a therapeutic agent for neurodegenerative diseases.

Wang Q, Chu CH, Oyarzabal E, Jiang L, Chen SH, Wilson B, Qian L, Hong JS.

Glia. 2014 Jul 17. doi: 10.1002/glia.22724. [Epub ahead of print]

PMID:
25043383
[PubMed - as supplied by publisher]
19.

[A comparative study of the efficacy of deep brain stimulation of the subthalamic nucleus and pharmacological treatment in advanced Parkinson's disease.]

Bril' EV, Tomskiĭ AA, Gamaleia AA, Shabalov VA, Fedorova NV, Dekopov AV, Bondarenko AA, Buklina SB, Gubareva NN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(6 Vypusk 2 Nevrologiia i psikhiatriia pozhilogo vozrasta):55-61. Russian.

PMID:
25042504
[PubMed - as supplied by publisher]
20.

[Freezing of gait in patients with Parkinson's disease.]

Skripkina NA, Levin OS.

Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(6 Vypusk 2 Nevrologiia i psikhiatriia pozhilogo vozrasta):41-48. Russian.

PMID:
25042502
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk